Lanreotide
26 interactions 3 explained in plain English
Medically reviewed by
Dr. Brian Staiger, PharmD, BCPS
· Updated Jul 4, 2026
· Editorial policy
· Data sources
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Most serious with:
Docetaxel
Dihydroergotamine Injection
Clindamycin Vaginal
Olaparib
Clindamycin Topical
Neratinib
Major
Lanreotide Clindamycin ANTIROBE Explained Altered exposure to CYP3A4 substrate Details Lanreotide Colchicine Colcrys Explained Altered exposure to CYP3A4 substrate Details Lanreotide Abemaciclib Verzenio Explained Altered exposure to CYP3A4 substrate Details Lanreotide Acalabrutinib Calquence Altered exposure to CYP3A4 substrate Details Lanreotide Axitinib Inlyta Altered exposure to CYP3A4 substrate Details Lanreotide Bosutinib Bosulif Altered exposure to CYP3A4 substrate Details Lanreotide Brigatinib Alunbrig Altered exposure to CYP3A4 substrate Details Lanreotide Clindamycin Injection ANTIROBE Altered exposure to CYP3A4 substrate Details Lanreotide Clindamycin Topical C/T/S® Altered exposure to CYP3A4 substrate Details Lanreotide Clindamycin Vaginal Cleocin Altered exposure to CYP3A4 substrate Details Lanreotide Cobimetinib Cotellic Altered exposure to CYP3A4 substrate Details Lanreotide Cyclosporine Injection Atopica Decrease the relative bioavailability of cycloSPORINE Details Lanreotide Cyclosporine Ophthalmic Cequa Decrease the relative bioavailability of cycloSPORINE Details Lanreotide Dasatinib Phyrago Altered exposure to CYP3A4 substrate Details Lanreotide Dihydroergotamine Injection DHE-45® Injection Altered exposure to CYP3A4 substrate Details Lanreotide Dihydroergotamine Nasal Spray Migranal Altered exposure to CYP3A4 substrate Details Lanreotide Docetaxel Beizray Altered exposure to CYP3A4 substrate Details Lanreotide Docetaxel Injection Beizray Altered exposure to CYP3A4 substrate Details Lanreotide Dofetilide Tikosyn Altered exposure to CYP3A4 substrate Details Lanreotide Entrectinib Rozlytrek Altered exposure to CYP3A4 substrate Details Lanreotide Everolimus Afinitor Altered exposure to CYP3A4 substrate Details Lanreotide Fentanyl Transdermal Patch Duragesic® Altered exposure to CYP3A4 substrate Details Lanreotide Midostaurin Rydapt Altered exposure to CYP3A4 substrate Details Lanreotide Neratinib Nerlynx Altered exposure to CYP3A4 substrate Details Lanreotide Olaparib Lynparza Altered exposure to CYP3A4 substrate DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacistEducational information only, not medical advice. Always confirm interactions with your pharmacist
or prescriber before making any change to your medications.